Johnson & Johnson Recalls Infant Tylenol

MARCH 13, 2012
Jeannette Y. Wick, RPh, MBA, FASCP
The pharmaceutical giant’s McNeil Consumer Healthcare unit issued yet another recall, this time due to malfunctioning bottles.
 


Johnson & Johnson issued a recall for OTC infant Tylenol last month due to problems with the bottle design. The new bottle, which was just introduced in November, is malfunctioning. The flow restrictor (at the top of the bottle) has been dislodging and falling into the bottle. There is nothing wrong with the medication itself, and consumers can continue to administer it.
 
In total, the voluntary recall affected 574,000 bottles of grape-flavored Tylenol, which were distributed across the country. Since September 2009, Johnson & Johnson’s McNeil Consumer Healthcare unit has issued approximately 25 recalls. McNeil has also been plagued by factory shutdowns for more than a year, leading to revenue losses of over $1 billion.
 
The exact product being recalled is Infants’ Tylenol Oral Suspension (1-ounce bottles), lots BIL0U00, BIL0V00, BIL3500, BJL2D00, BJL2E00, BJL2T00, and BJL2U00. Consumers can apply for a refund at the product recall website.

Ms. Wick is a visiting professor at the University of Connecticut School of Pharmacy and a freelance writer from Virginia.

SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.